{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:31:00Z","timestamp":1780497060112,"version":"3.54.1"},"reference-count":66,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2024,5,1]]},"abstract":"Importance<\/jats:title>Dermatologists prescribe more oral antibiotics per clinician than clinicians in any other specialty. Despite clinical guidelines that recommend limitation of long-term oral antibiotic treatments for acne to less than 3 months, there is little evidence to guide the design and implementation of an antibiotic stewardship program in clinical practice.<\/jats:p><\/jats:sec>Objective<\/jats:title>To identify salient barriers and facilitators to long-term antibiotic prescriptions for acne treatment.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This qualitative study assessed data collected from stakeholders (including dermatologists, infectious disease physicians, dermatology resident physicians, and nonphysician clinicians) via an online survey and semistructured video interviews between March and August 2021. Data analyses were performed from August 12, 2021, to January 20, 2024.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Online survey and qualitative video interviews developed with the Theoretical Domains Framework. Thematic analyses were used to identify salient themes on barriers and facilitators to long-term antibiotic prescriptions for acne treatment.<\/jats:p><\/jats:sec>Results<\/jats:title>Among 30 participants (14 [47%] males and 16 [53%] females) who completed the study requirements and were included in the analysis, knowledge of antibiotic guideline recommendations was high and antibiotic stewardship was believed to be a professional responsibility. Five salient themes were to be affecting long-term antibiotic prescriptions: perceived lack of evidence to justify change in dermatologic practice, difficulty navigating patient demands and satisfaction, discomfort with discussing contraception, iPLEDGE-related barriers, and the absence of an effective system to measure progress on antibiotic stewardship.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>The findings of this qualitative study indicate that multiple salient factors affect long-term antibiotic prescribing practices for acne treatment. These factors should be considered in the design and implementation of any future outpatient antibiotic stewardship program for clinical dermatology.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamadermatol.2024.0203","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T15:00:46Z","timestamp":1712156446000},"page":"535","source":"Crossref","is-referenced-by-count":8,"title":["Barriers and Facilitators Affecting Long-Term Antibiotic Prescriptions for Acne Treatment"],"prefix":"10.1001","volume":"160","author":[{"given":"Ronnie A.","family":"Festok","sequence":"first","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avni S.","family":"Ahuja","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared Y.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Barron","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Case","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suephy C.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Duke University School of Medicine, Durham, North Carolina"},{"name":"Division of Dermatology, Durham VA Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Swerlick","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cam","family":"Escoffery","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howa","family":"Yeung","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Associate Editor, JAMA Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"doi240005r1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jaad.2015.11.025","article-title":"Staphylococcus aureus carriage rates and antibiotic resistance patterns in patients with acne vulgaris.","volume":"74","author":"Delost","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi240005r2","doi-asserted-by":"publisher","DOI":"10.3399\/BJGPO.2020.0181","article-title":"Is there an association between long-term antibiotics for acne and subsequent infection sequelae and antimicrobial resistance? A systematic review.","volume":"5","author":"Bhate","year":"2021","journal-title":"BJGP Open"},{"issue":"4","key":"doi240005r3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/archderm.139.4.467","article-title":"Effect of antibiotics on the oropharyngeal flora in patients with acne.","volume":"139","author":"Levy","year":"2003","journal-title":"Arch Dermatol"},{"issue":"9","key":"doi240005r4","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/archderm.141.9.1132","article-title":"Antibiotic treatment of acne may be associated with upper respiratory tract infections.","volume":"141","author":"Margolis","year":"2005","journal-title":"Arch Dermatol"},{"issue":"3","key":"doi240005r5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/archdermatol.2011.355","article-title":"Association of pharyngitis with oral antibiotic use for the treatment of acne: a cross-sectional and prospective cohort study.","volume":"148","author":"Margolis","year":"2012","journal-title":"Arch Dermatol"},{"issue":"12","key":"doi240005r6","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1038\/ajg.2010.303","article-title":"Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease.","volume":"105","author":"Margolis","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"doi240005r7","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jama.291.7.827","article-title":"Antibiotic use in relation to the risk of breast cancer.","volume":"291","author":"Velicer","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"doi240005r8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10620-015-3828-0","article-title":"Frequent use of antibiotics is associated with colorectal cancer risk: results of a nested case-control study.","volume":"61","author":"Dik","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"5","key":"doi240005r9","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris.","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi240005r10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/jamadermatol.2018.4944","article-title":"Trends in oral antibiotic prescription in dermatology, 2008 to 2016.","volume":"155","author":"Barbieri","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"1","key":"doi240005r11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jaad.2014.02.031","article-title":"A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: investigating practice gaps and potential cost-savings.","volume":"71","author":"Lee","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi240005r12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jaad.2015.01.048","article-title":"Duration of oral antibiotic therapy for the treatment of adult acne: a retrospective analysis investigating adherence to guideline recommendations and opportunities for cost-savings.","volume":"72","author":"Straight","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi240005r13","first-page":"376","article-title":"Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 3: oral therapies.","volume":"96","author":"Del Rosso","year":"2015","journal-title":"Cutis"},{"issue":"6","key":"doi240005r14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6506a1","article-title":"Core elements of outpatient antibiotic stewardship.","volume":"65","author":"Sanchez","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"doi240005r15","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1016\/j.jaad.2022.03.069","article-title":"Developing and implementing approaches to limit antimicrobial resistance.","volume":"87","author":"Chu","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi240005r16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems.","volume":"12","author":"Atkins","year":"2017","journal-title":"Implement Sci"},{"issue":"2","key":"doi240005r18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology.","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"issue":"1","key":"doi240005r19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions.","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"issue":"4","key":"doi240005r20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/1049732316665344","article-title":"Code saturation versus meaning saturation: how many interviews are enough?","volume":"27","author":"Hennink","year":"2017","journal-title":"Qual Health Res"},{"key":"doi240005r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114523","article-title":"Sample sizes for saturation in qualitative research: a systematic review of empirical tests.","volume":"292","author":"Hennink","year":"2022","journal-title":"Soc Sci Med"},{"issue":"10","key":"doi240005r23","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/cid\/ciw217","article-title":"Executive summary: implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"doi240005r24","first-page":"18","article-title":"Status report from the scientific panel on antibiotic use in dermatology of the American Acne and Rosacea Society: part 1, antibiotic prescribing patterns, sources of antibiotic exposure, antibiotic consumption and emergence of antibiotic resistance, impact of alterations in antibiotic prescribing, and clinical sequelae of antibiotic use.","volume":"9","author":"Del Rosso","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"issue":"8","key":"doi240005r25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/jde.v47.8","article-title":"Characterization of acne patients carrying clindamycin-resistant Cutibacterium acnes: a Japanese multicenter study.","volume":"47","author":"Nakase","year":"2020","journal-title":"J Dermatol"},{"key":"doi240005r26","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.787299","article-title":"C. acnes qPCR-based Antibiotics Resistance Assay (ACQUIRE) reveals widespread macrolide resistance in acne patients and can eliminate macrolide misuse in acne treatment.","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Public Health"},{"issue":"2","key":"doi240005r27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/09546634.2016.1214234","article-title":"The extinction of topical erythromycin therapy for acne vulgaris and concern for the future of topical clindamycin.","volume":"28","author":"Austin","year":"2017","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"doi240005r28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12895-020-00108-9","article-title":"Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.","volume":"20","author":"Alkhawaja","year":"2020","journal-title":"BMC Dermatol"},{"issue":"625","key":"doi240005r29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd8077","article-title":"Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics.","volume":"13","author":"Jo","year":"2021","journal-title":"Sci Transl Med"},{"issue":"9452","key":"doi240005r30","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/S0140-6736(04)17591-0","article-title":"Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial.","volume":"364","author":"Ozolins","year":"2004","journal-title":"Lancet"},{"key":"doi240005r31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-074349","article-title":"Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial.","volume":"381","author":"Santer","year":"2023","journal-title":"BMJ"},{"issue":"6","key":"doi240005r32","first-page":"30","article-title":"Patient awareness of antimicrobial resistance and antibiotic use in acne vulgaris.","volume":"12","author":"Del Rosso","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"issue":"10","key":"doi240005r33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076691","article-title":"Are patient views about antibiotics related to clinician perceptions, management and outcome? a multi-country study in outpatients with acute cough.","volume":"8","author":"Coenen","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"doi240005r34","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1001\/archpedi.160.9.945","article-title":"Ruling out the need for antibiotics: are we sending the right message?","volume":"160","author":"Mangione-Smith","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"doi240005r35","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1093\/ofid\/ofaa417.021","article-title":"Patient satisfaction remains unchanged following implementation of an antibiotic stewardship intervention in primary care.","volume":"7","author":"Hostetler","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"doi240005r36","doi-asserted-by":"publisher","first-page":"S693","DOI":"10.1093\/ofid\/ofz360.1738","article-title":"Patient satisfaction not impacted by antibiotic prescribing for viral upper respiratory infections.","volume":"6","author":"Ray","year":"2058","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"doi240005r37","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.amjmed.2010.05.009","article-title":"Adherence to oral contraception in women on category X medications.","volume":"123","author":"Steinkellner","year":"2010","journal-title":"Am J Med"},{"issue":"4","key":"doi240005r38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3109\/09546634.2012.671908","article-title":"Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey.","volume":"23","author":"Landis","year":"2012","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"doi240005r39","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1001\/jamadermatol.2013.6862","article-title":"Women\u2019s experiences with isotretinoin risk reduction counseling.","volume":"150","author":"Werner","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"4","key":"doi240005r40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/jamadermatol.2014.4171","article-title":"Promoting safe use of isotretinoin by increasing contraceptive knowledge.","volume":"151","author":"Werner","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"17","key":"doi240005r41","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1001\/jama.2022.11489","article-title":"Threats to evidence-based care with teratogenic medications in states with abortion restrictions.","volume":"328","author":"Rubin","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"doi240005r42","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jaad.2022.07.026","article-title":"The Supreme Court abortion ban impact on dermatology.","volume":"87","author":"Yousif","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi240005r43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jpag.2013.05.007","article-title":"Isotretinoin: update on controversial issues.","volume":"26","author":"Prevost","year":"2013","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"doi240005r44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamadermatol.2019.3270","article-title":"Isotretinoin, patient safety, and patient-centered care-time to reform iPLEDGE.","volume":"156","author":"Barbieri","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"3","key":"doi240005r45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/jamadermatol.2015.4763","article-title":"Personal burden of isotretinoin therapy and willingness to pay for electronic follow-up visits.","volume":"152","author":"Mori","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"1","key":"doi240005r46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaad.2020.02.022","article-title":"Simplifying contraception requirements for iPLEDGE: a decision analysis.","volume":"83","author":"Barbieri","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi240005r47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.12788\/cutis","article-title":"Telemedicine and home pregnancy testing for iPLEDGE: a survey of clinician perspectives.","volume":"110","author":"Barbieri","year":"2022","journal-title":"Cutis"},{"key":"doi240005r48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/pde.v38.s2","article-title":"The future of iPLEDGE: We pledge for more inclusive access to isotretinoin.","volume":"38","author":"Shah","year":"2021","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"doi240005r49","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1017\/ice.2014.41","article-title":"Antimicrobial stewardship in outpatient settings: a systematic review.","volume":"36","author":"Drekonja","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"13","key":"doi240005r50","doi-asserted-by":"publisher","first-page":"E726","DOI":"10.1503\/cmaj.120568","article-title":"Training family physicians in shared decision-making to reduce the overuse of antibiotics in acute respiratory infections: a cluster randomized trial.","volume":"184","author":"L\u00e9gar\u00e9","year":"2012","journal-title":"CMAJ"},{"issue":"Suppl 1","key":"doi240005r51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/hex.2011.14.issue-s1","article-title":"Training family physicians in shared decision making for the use of antibiotics for acute respiratory infections: a pilot clustered randomized controlled trial.","volume":"14","author":"L\u00e9gar\u00e9","year":"2011","journal-title":"Health Expect"},{"issue":"4","key":"doi240005r52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.amjmed.2012.10.027","article-title":"Effects of clinical pathways for common outpatient infections on antibiotic prescribing.","volume":"126","author":"Jenkins","year":"2013","journal-title":"Am J Med"},{"issue":"3","key":"doi240005r53","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jamainternmed.2013.14191","article-title":"Nudging guideline-concordant antibiotic prescribing: a randomized clinical trial.","volume":"174","author":"Meeker","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"22","key":"doi240005r54","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1001\/jama.2013.6287","article-title":"Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial.","volume":"309","author":"Gerber","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"doi240005r55","first-page":"28","article-title":"Antimicrobial stewardship metrics: prospective audit with intervention and feedback.","volume":"101","author":"Dorobisz","year":"2018","journal-title":"R I Med J"},{"issue":"14","key":"doi240005r56","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1001\/jama.2017.11152","article-title":"Effects of behavioral interventions on inappropriate antibiotic prescribing in primary care 12 months after stopping interventions.","volume":"318","author":"Linder","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"doi240005r58","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/antibiotics11101306","article-title":"Exploring antimicrobial stewardship influential interventions on improving antibiotic utilization in outpatient and inpatient settings: a systematic review and meta-analysis.","volume":"11","author":"Sadeq","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"doi240005r59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1748-5908-8-81","article-title":"Development and initial validation of the influences on patient safety behaviours questionnaire.","volume":"8","author":"Taylor","year":"2013","journal-title":"Implement Sci"},{"issue":"8","key":"doi240005r60","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/jdv.2016.30.issue-8","article-title":"European evidence-based (S3) guideline for the treatment of acne - update 2016-short version.","volume":"30","author":"Nast","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"doi240005r61","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.adengl.2016.10.003","article-title":"Consensus-based acne classification system and treatment algorithm for Spain.","volume":"108","author":"L\u00f3pez-Estebaranz","year":"2017","journal-title":"Actas Dermosifiliogr"},{"issue":"713","key":"doi240005r62","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3399\/bjgp21X717977","article-title":"New NICE guidance on acne vulgaris: implications for first-line management in primary care.","volume":"71","author":"Wilcock","year":"2021","journal-title":"Br J Gen Pract"},{"issue":"8","key":"doi240005r63","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/jde.2018.45.issue-8","article-title":"Japanese Dermatological Association Guidelines: guidelines for the treatment of acne vulgaris, 2017.","volume":"45","author":"Hayashi","year":"2018","journal-title":"J Dermatol"},{"issue":"1","key":"doi240005r64","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s13063-020-04432-w","article-title":"FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.","volume":"21","author":"Poinas","year":"2020","journal-title":"Trials"},{"issue":"12","key":"doi240005r65","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.36849\/JDD.2020","article-title":"Optimizing the trial design for a comparative effectiveness study of spironolactone versus oral antibiotics for women with acne: a Delphi consensus Panel.","volume":"19","author":"Barbieri","year":"2020","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"doi240005r66","first-page":"632","article-title":"Frequency of treatment switching for spironolactone compared to oral tetracycline-class antibiotics for women with acne: a retrospective cohort study 2010-2016.","volume":"17","author":"Barbieri","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"doi240005r57","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-3-030-55829-1_15","volume-title":"Patient Safety and Quality Improvement in Healthcare: A Case-Based Approach","author":"Stevens","year":"2021"},{"key":"doi240005r17","doi-asserted-by":"crossref","unstructured":"Drwiega? EN, Griffith? N, Herald? F, Badowski? ME. How to design and implement an outpatient antimicrobial stewardship programme. Drugs Context. 2023;12.","DOI":"10.7573\/dic.2022-8-2"},{"key":"doi240005r22","unstructured":"iPLEDGE REMS. Accessed February 29, 2024. https:\/\/ipledgeprogram.com\/#Main\/PublicHome"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2817136\/jamadermatology_festok_2024_oi_240005_1715718006.59577.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T15:03:16Z","timestamp":1715785396000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2817136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2024.0203","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,1]]}}}